Go Makimoto
8PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 13, 2026
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study.Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi
|Jul 01, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity.Yuto Naoi, Yumi Inukai, Tomoka Izumikawa
|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi
|Sep 19, 2024
Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.Kiichiro Ninomiya, Daisuke Ennishi, Kunio Okamoto
|Sep 15, 2023
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.Chihiro Ando, Eiki Ichihara, Tatsuya Nishi
|Jul 08, 2022
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida
Pageof 2
Frequent Collaborators
5 joint publications
Eiki Ichihara
5 joint publications
Kadoaki Ohashi
4 joint publications
Shuta Tomida
4 joint publications
Yoshinobu Maeda
4 joint publications
Kiichiro Ninomiya
3 joint publications
Hirohisa Kano
3 joint publications
Katuyuki Hotta
3 joint publications
Shinichi Toyooka
2 joint publications
Takamasa Nakasuka
2 joint publications
Atsuko Hirabae
